Deserpidine/Methyclothiazide

The aim was to validate possible vasodilating effects of a Ginkgo biloba extract with a secondary aim of finding a pharmacodynamic signal relating to the active component of these extracts. We studied the effect of G. biloba extract on forearm haemodynamics in 16 healthy subjects (nine females, seven males) with a median age of 32 years (range: 21–47). The study was conducted as a randomized, double‐blinded cross‐over design using oral treatment with G. biloba extract (Gibidyl Forte® t.i.d. or placebo for 6 weeks. Forearm blood flow and venous capacity were measured by strain‐gauge plethysmography. Blood pressure was measured by standard sphygmomanometry, and forearm vascular resistance (FVR) was derived. Measurements were made at baseline and after 3, 6, 9 and 12 weeks of treatment. Forearm blood flow was significantly higher during active treatment after 3 and 6 weeks as compared with placebo treatment for 3 and 6 weeks (P<0·05). Mean arterial blood pressure was unchanged, making the calculated FVR significantly lower during active treatment (P<0·02). It is concluded that oral treatment with a G. biloba extract (Gibidyl Forte®) is able to dilate forearm blood vessels causing increments in regional blood flow without changing blood pressure levels in healthy subjects. The increments in blood flow may be used as a biological signal for pharmacokinetic studies.